Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency

G. W. Neff, M. Montalbano, G. Slapak-Green, D. Meyer, T. Berney, K. Safdar, Eugene R Schiff, A. G. Tzakis

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Calcineurin inhibitor-related renal toxicity affects patient and graft survival in transplant recipients. Our clinical experience has revealed sirolimus to be an effective agent in treating renal insufficiency related to calcineurin inhibitor toxicity. Methods. We performed a retrospective review of the medical records of OLT recipients suffering from chronic renal insufficiency and treated with sirolimus at the University of Miami. Results. Fourteen patients (nine men and five women) of mean age 57 years who had been treated with tacrolimus for at least 30 days were converted to sirolimus after developing nephrotoxicity. Mean creatinine clearances collected on day 0, 30, 60, and 90 after conversion were 40.1 mL/min, 49.6 mL/min, 53.9 mL/min, and 51. 4 mL/min, respectively. Episodes of acute cellular rejection were not increased during the sirolimus conversion. Conclusion. This retrospective review suggests that OLT patients suffering from tacrolimus-related renal insufficiency successfully converted to sirolimus may benefit from this therapy.

Original languageEnglish
Pages (from-to)3029-3031
Number of pages3
JournalTransplantation Proceedings
Volume35
Issue number8
DOIs
StatePublished - Dec 1 2003

Fingerprint

Sirolimus
Chronic Renal Insufficiency
Liver
Tacrolimus
Renal Insufficiency
Therapeutics
Graft Survival
Medical Records
Creatinine
Transplant Recipients
Calcineurin Inhibitors
Kidney

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency. / Neff, G. W.; Montalbano, M.; Slapak-Green, G.; Meyer, D.; Berney, T.; Safdar, K.; Schiff, Eugene R; Tzakis, A. G.

In: Transplantation Proceedings, Vol. 35, No. 8, 01.12.2003, p. 3029-3031.

Research output: Contribution to journalArticle

Neff, G. W. ; Montalbano, M. ; Slapak-Green, G. ; Meyer, D. ; Berney, T. ; Safdar, K. ; Schiff, Eugene R ; Tzakis, A. G. / Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency. In: Transplantation Proceedings. 2003 ; Vol. 35, No. 8. pp. 3029-3031.
@article{aaa7b3e0d1bc4c49bdbf7e291e59f3f7,
title = "Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency",
abstract = "Calcineurin inhibitor-related renal toxicity affects patient and graft survival in transplant recipients. Our clinical experience has revealed sirolimus to be an effective agent in treating renal insufficiency related to calcineurin inhibitor toxicity. Methods. We performed a retrospective review of the medical records of OLT recipients suffering from chronic renal insufficiency and treated with sirolimus at the University of Miami. Results. Fourteen patients (nine men and five women) of mean age 57 years who had been treated with tacrolimus for at least 30 days were converted to sirolimus after developing nephrotoxicity. Mean creatinine clearances collected on day 0, 30, 60, and 90 after conversion were 40.1 mL/min, 49.6 mL/min, 53.9 mL/min, and 51. 4 mL/min, respectively. Episodes of acute cellular rejection were not increased during the sirolimus conversion. Conclusion. This retrospective review suggests that OLT patients suffering from tacrolimus-related renal insufficiency successfully converted to sirolimus may benefit from this therapy.",
author = "Neff, {G. W.} and M. Montalbano and G. Slapak-Green and D. Meyer and T. Berney and K. Safdar and Schiff, {Eugene R} and Tzakis, {A. G.}",
year = "2003",
month = "12",
day = "1",
doi = "10.1016/j.transproceed.2003.10.002",
language = "English",
volume = "35",
pages = "3029--3031",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "8",

}

TY - JOUR

T1 - Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiency

AU - Neff, G. W.

AU - Montalbano, M.

AU - Slapak-Green, G.

AU - Meyer, D.

AU - Berney, T.

AU - Safdar, K.

AU - Schiff, Eugene R

AU - Tzakis, A. G.

PY - 2003/12/1

Y1 - 2003/12/1

N2 - Calcineurin inhibitor-related renal toxicity affects patient and graft survival in transplant recipients. Our clinical experience has revealed sirolimus to be an effective agent in treating renal insufficiency related to calcineurin inhibitor toxicity. Methods. We performed a retrospective review of the medical records of OLT recipients suffering from chronic renal insufficiency and treated with sirolimus at the University of Miami. Results. Fourteen patients (nine men and five women) of mean age 57 years who had been treated with tacrolimus for at least 30 days were converted to sirolimus after developing nephrotoxicity. Mean creatinine clearances collected on day 0, 30, 60, and 90 after conversion were 40.1 mL/min, 49.6 mL/min, 53.9 mL/min, and 51. 4 mL/min, respectively. Episodes of acute cellular rejection were not increased during the sirolimus conversion. Conclusion. This retrospective review suggests that OLT patients suffering from tacrolimus-related renal insufficiency successfully converted to sirolimus may benefit from this therapy.

AB - Calcineurin inhibitor-related renal toxicity affects patient and graft survival in transplant recipients. Our clinical experience has revealed sirolimus to be an effective agent in treating renal insufficiency related to calcineurin inhibitor toxicity. Methods. We performed a retrospective review of the medical records of OLT recipients suffering from chronic renal insufficiency and treated with sirolimus at the University of Miami. Results. Fourteen patients (nine men and five women) of mean age 57 years who had been treated with tacrolimus for at least 30 days were converted to sirolimus after developing nephrotoxicity. Mean creatinine clearances collected on day 0, 30, 60, and 90 after conversion were 40.1 mL/min, 49.6 mL/min, 53.9 mL/min, and 51. 4 mL/min, respectively. Episodes of acute cellular rejection were not increased during the sirolimus conversion. Conclusion. This retrospective review suggests that OLT patients suffering from tacrolimus-related renal insufficiency successfully converted to sirolimus may benefit from this therapy.

UR - http://www.scopus.com/inward/record.url?scp=0346500880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346500880&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2003.10.002

DO - 10.1016/j.transproceed.2003.10.002

M3 - Article

C2 - 14697970

AN - SCOPUS:0346500880

VL - 35

SP - 3029

EP - 3031

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 8

ER -